Artificial intelligence

Artificial intelligence has been studied in 151 papers since 2019: 1 trial and 12 observational studies in people, 134 reviews; 115 in the past year. The newest paper, Nov 18, 2026: “Artificial Intelligence and Cardiovascular Disease Prevention: Newton's Second Law Readdressed with a Cautionary Note”.

Intervention

151 papers study it130 findingsUpdated

MeSH

Research on it is growing 57% faster than aging research as a whole: 446 papers in the latest year counted

16 new papers in 30 daysSee all 147 papers on artificial intelligence

At a glance

Reviews describe artificial intelligence predicting hip fractures, frailty, and dementia in humans, with independent labs reporting hip-fracture prediction. A human trial reports improved cancer detection and reduced screening workload; another shows no clear effect on gastric neoplasm detection. Authors include company employees, and papers declare company ties.

130 findings in 94 papers from 2019 to 2026, 39 of them since April 2026

Independent labs found the same change in people. 41 independent labs in 19 countries.

“AI did not improve detection rate of gastric neoplasm after pathological review (RR, 1.13; 0.92-1.38; 1.42 vs 1.25%; P = .25).”
Effect of a Computer-Aided Device for Detecting Gastric Neoplasms: A Multicenter, Randomized Controlled TrialGastroenterology2026doi:10.1053/j.gastro.2025.12.020

None of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 41 independent labs in 19 countries
  • Funders: National Institutes of Health and others
  • 5 of 60 findings with company ties
  • Human trial1
  • Humans12
  • In silico3

Studies in people

1 study gave artificial intelligence to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on detection of gastric neoplasms

down: Decreases blind spots2.52 to 1.07, P < .001

Randomized trial29,514 peopleGeneral population; after pathological reviewGastroenterology, Mar 9, 2026

What did studies of artificial intelligence find?

77

Studies of artificial intelligence measured 77 outcomes; the most studied are diagnostic accuracy (6 studies), breast cancer detection rate (3) and risk stratification (2).

Diagnostic accuracy

upin humans5upin reviews1

6 studies
  1. Artificial intelligence improves diagnostic accuracy in humans (Alzheimer's disease early diagnosis).

    “Artificial intelligence (AI) and machine learning techniques may improve diagnostic accuracy by analyzing multiple biomarkers simultaneously”

    ReviewAlzheimer's disease early diagnosis

    Artificial Intelligence-Assisted Blood Bi omarker Analysis for Early Detection of Alzheimer's Disease

    Theoretical and Natural Science

  2. Artificial intelligence improves diagnostic accuracy in breast cancer screening.

    “the improved accuracy of diagnosing breast cancer”

    Reviewin breast cancer screening

    AI Driven Precision in Breast Cancer Screening: Transforming Early Detection

    International Conference on Inventive Computation Technologies (ICICT)

  3. Artificial intelligence improves diagnostic accuracy in humans (AUC 0.82 vs. 0.72).

    “AI-driven 3D volumetric analysis outperformed traditional 2D DXA densitometry (AUC 0.82 vs. 0.72)”

    Review

    Applications of Artificial Intelligence in Opportunistic Screening and Diagnostic Imaging of Osteoporotic Fractures: A Systematic Review

    Journal of Education Health and Sport

  4. Artificial intelligence improves diagnostic accuracy in humans (88-96% accuracy).

    “AI tools in upper GI endoscopy achieve diagnostic accuracies of 88-96% for early esophageal and gastric neoplasia, outperforming non-expert endoscopists.”

    Review

    Artificial Intelligence in Gastrointestinal Endoscopy: Current Advances, Clinical Integration, and Future Directions: A Narrative Review

    Clinical and experimental gastroenterology

  5. Artificial intelligence increases diagnostic accuracy in humans.

    “AI models, particularly DL applied to neuroimaging, electrophysiological data, speech and language features, biomarkers, and digital behavioral data, achieve high diagnostic accuracy in distinguishing MCI, Alzheimer’s disease, and healthy aging.”

    Reviewapplied to neuroimaging, electrophysiological data, speech and language features, biomarkers, and digital behavioral data

    The Role of Artificial Intelligence in the Detection and Diagnosis of Neurocognitive Disorders: A Systematic Review

    Technologies

  6. Artificial intelligence increases diagnostic accuracy (cardiovascular diagnostics).

    “Key findings indicate that AI systems consistently achieve higher diagnostic accuracy, reduce inter-observer variability, and facilitate earlier detection of cardiovascular conditions, leading to improved patient outcomes.”

    Reviewcardiovascular diagnostics

    Artificial intelligence in cardiology: an updated systematic review with ethical considerations and challenges in implementing artificial intelligence models

    Annals of medicine and surgery (2012)

More on Diagnostic accuracy

Breast cancer detection rate

upin humans3

3 studies
  1. Artificial intelligence is linked with better breast cancer detection rate in humans (screening digital breast tomosynthesis) (+1.34 (95% CI, 0.33 to 2.36)).

    “CDR improved from 6.23 to 7.57, an increase of 1.34 (95% confidence interval [CI], 0.33 to 2.36; P < .01).”

    Humansscreening digital breast tomosynthesis

    Artificial Intelligence Impact on Radiologist Performance in Breast Cancer Screening With Digital Breast Tomosynthesis

    Journal of the American College of Radiology : JACR

  2. Artificial intelligence increases breast cancer detection rate in humans (mammography-based breast cancer screening).

    “AI increased or maintained the breast cancer detection rate in several scenarios, including the identification of recurrences”

    Reviewmammography-based breast cancer screeningbreast

    Deep Learning-Based Artificial Intelligence for Breast Cancer Detection in Mammography: A Systematic Review

    Ibero Ciencias - Revista Científica y Académica

  3. Artificial intelligence increases breast cancer detection rate in humans (AI-assisted digital breast tomosynthesis reading compared with human reading alone) (+3.8‰).

    “DBT with AI-assisted reading compared to human reading alone increased the detection rate in a prospective study by +3.8‰”

    ReviewAI-assisted digital breast tomosynthesis reading compared with human reading alonebreast

    Digital breast tomosynthesis and reading with artificial intelligence

    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

Risk stratification

upin humans2

2 studies
  1. Artificial intelligence improves risk stratification in humans (compared with conventional clinical scores).

    “machine-learning models integrating multimodality imaging data improve risk stratification over conventional clinical scores”

    Reviewcompared with conventional clinical scoresmachine-learning models integrating multimodality imaging data

    Artificial Intelligence in Coronary Artery Disease: From Detection to Precision Management

    Methodist DeBakey cardiovascular journal

  2. Artificial intelligence improves risk stratification in humans (detection).

    “AI models integrate multimarker blood panels, routine laboratory indicators, ultrasound imaging, and cell-free DNA (cfDNA)-derived molecular signals to improve risk stratification beyond traditional biomarkers”

    Reviewdetection

    Artificial intelligence in ovarian cancer prevention and control: a brief review of detection, treatment, and equity (2021-2026)

    Frontiers in oncology

Screening workload

downin humans2−31% reduction

2 studies
  1. Artificial intelligence decreases screening workload in humans (up to 31% reduction).

    “The primary AI workflow could improve cancer detection by 10.4% (1 per 1,000), maintain the recall rate (0.8% reduction) and reduce workload by up to 31%.”

    Human trialn = 10,889

    Prospective evaluation of artificial intelligence integration into breast cancer screening in multiple workflow settings: the GEMINI study

    Nature cancer

  2. Artificial intelligence decreases screening workload in humans (screening mammography) (mean workload reduction of 42.9% (SD 1.5%)).

    “There was a mean workload reduction of 42.9% (SD 1.5%) with AI integration.”

    Reviewscreening mammography

    The Efficacy and Workload Impact of AI-Integrated Workflows vs. Traditional Human Double-Reading in Ductal Carcinoma in situ Screening: A Meta-Analysis

    Global Journal of Health Science

Recall rate

no changein humans2RR 1.19

2 studies
  1. Artificial intelligence was not clearly linked with recall rate in humans (screening digital breast tomosynthesis) (-0.01% (95% CI, -0.32% to 0.30%)).

    “The recall rate was 6.97% pre-AI and 6.96% post-AI, a decrease of 0.01% (95% CI, -0.32% to 0.30%; P = .47).”

    Humansscreening digital breast tomosynthesis

    Artificial Intelligence Impact on Radiologist Performance in Breast Cancer Screening With Digital Breast Tomosynthesis

    Journal of the American College of Radiology : JACR

  2. Artificial intelligence showed no clear effect on recall rate in humans (screening mammography) (pooled RR 1.19, 95% CI 0.87-1.62, p = 0.275).

    “The outcomes for recall rates were not significantly different overall with AI use (pooled RR 1.19, 95% CI 0.87-1.62, I2 = 98.6%, p = 0.275).”

    Reviewscreening mammography

    The Efficacy and Workload Impact of AI-Integrated Workflows vs. Traditional Human Double-Reading in Ductal Carcinoma in situ Screening: A Meta-Analysis

    Global Journal of Health Science

Radiologist workload

downin humans2

2 studies
  1. Artificial intelligence decreases radiologist workload in humans (AI-integrated workflows (triage and second-reader replacement)).

    “Prospective evaluations of AI-integrated workflows, including triage and second-reader replacement, showed non-inferior cancer detection with significant workload reduction compared with standard double reading.”

    ReviewAI-integrated workflows (triage and second-reader replacement)

    Diagnostic performance of FDA-cleared and CE-marked AI systems for mammography screening: a systematic review and meta-analysis

    European journal of radiology

  2. Artificial intelligence decreases radiologist workload in humans (prospective trials in mammography).

    “demonstrate non‐inferior cancer detection with large reductions in radiologist workload”

    Reviewprospective trials in mammography

    AI for screening in healthcare: promise and challenges

    Abdominal radiology (New York)

Early identification of coronary artery disease

upin humans1

1 study
  1. Artificial intelligence improves early identification of coronary artery disease in humans (screening).

    “In screening, deep-learning electrocardiography and electronic health record-based digital markers enable earlier identification of clinically significant disease.”

    Reviewscreening

    Artificial Intelligence in Coronary Artery Disease: From Detection to Precision Management

    Methodist DeBakey cardiovascular journal

Mammography reading workload

downin humans1

1 study
  1. Artificial intelligence decreases mammography reading workload in humans (appropriately integrated into mammography screening).

    “suggest that appropriately integrated AI can improve cancer detection and reduce reading workload without necessarily increasing false-positive outcomes.”

    Reviewappropriately integrated into mammography screeningbreast

    ARTIFICIAL INTELLIGENCE IN MAMMOGRAPHY: CURRENT APPLICATION AND FUTURE PERSPECTIVES

    Acta Innovations

Cancer detection

upin humans1

1 study
  1. Artificial intelligence improves cancer detection in humans (appropriately integrated into mammography screening).

    “suggest that appropriately integrated AI can improve cancer detection and reduce reading workload without necessarily increasing false-positive outcomes.”

    Reviewappropriately integrated into mammography screeningbreast

    ARTIFICIAL INTELLIGENCE IN MAMMOGRAPHY: CURRENT APPLICATION AND FUTURE PERSPECTIVES

    Acta Innovations

Prediction of diabetes onset and diabetes-related complications

upin reviews1

1 study
  1. Artificial intelligence improves prediction of diabetes onset and diabetes-related complications.

    “AI-based models have demonstrated improved performance in predicting DM onset and diabetes-related complications by integrating electronic health records, imaging data, and longitudinal clinical variables.”

    ReviewAI-based models

    Artificial intelligence in diabetes: Clinical applications across the disease continuum

    Journal of diabetes and its complications

Cancer detection rate

upin humans1

1 study
  1. Artificial intelligence improves cancer detection rate in humans (+10.4% (1 per 1,000)).

    “The primary AI workflow could improve cancer detection by 10.4% (1 per 1,000), maintain the recall rate (0.8% reduction) and reduce workload by up to 31%.”

    Human trialn = 10,889

    Prospective evaluation of artificial intelligence integration into breast cancer screening in multiple workflow settings: the GEMINI study

    Nature cancer

Blind spots

downin humans1

1 study
  1. Artificial intelligence decreases blind spots in humans during upper endoscopy (2.52 to 1.07, P < .001).

    “AI reduced blind spots number from 2.52 to 1.07 (P < .001)”

    Human trialduring upper endoscopy

    Effect of a Computer-Aided Device for Detecting Gastric Neoplasms: A Multicenter, Randomized Controlled Trial

    Gastroenterology

Detection of gastric neoplasms

no changein humans1

1 study
  1. Artificial intelligence showed no clear effect on detection of gastric neoplasms in humans after pathological review.

    “AI did not improve detection rate of gastric neoplasm after pathological review (RR, 1.13; 0.92-1.38; 1.42 vs 1.25%; P = .25).”

    Human trialafter pathological review

    Effect of a Computer-Aided Device for Detecting Gastric Neoplasms: A Multicenter, Randomized Controlled Trial

    Gastroenterology

All 77

What is artificial intelligence linked with?

37

Studies link artificial intelligence with 37 measures, among them breast cancer, accuracy and atrial fibrillation.

Breast cancer

upin humans1no changein humans1

2 studies
  1. Artificial intelligence is associated with breast cancer in humans (2.9% vs 0.6%).

    “malignancy rates were 0.6% (1/154) among non-flagged SVAs and 2.9% (2/68) among AI-flagged SVAs (P = .17).”

    Humansbreastfemales

    Outcomes of Single-View Asymmetries Recalled From Screening Mammography and Exploratory Analysis of AI Detection

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes

  2. Artificial intelligence is associated with breast cancer in randomised and paired prospective trials (rate ratio 1.13 (0.83-1.55)).

    “Across randomised and paired prospective trials (k = 3), the pooled detection rate ratio was 1.13 (0.83-1.55)”

    Reviewin randomised and paired prospective trials

    Ten Years of Artificial Intelligence in Screening Mammography: A Systematic Review and Meta-Analysis of Diagnostic Accuracy and Clinical Implementation (Literature Published 2015-2025)

    Diagnostics (Basel, Switzerland)

More on Breast cancer

Accuracy

upin humans2

2 studies
  1. Artificial intelligence predicts accuracy in humans (AUC 0.890 (95% CI 0.858-0.915)).

    “Pooled standalone AUC across 14 studies and 1,214,885 examinations was 0.890 (95% CI 0.858-0.915)”

    Review

    Ten Years of Artificial Intelligence in Screening Mammography: A Systematic Review and Meta-Analysis of Diagnostic Accuracy and Clinical Implementation (Literature Published 2015-2025)

    Diagnostics (Basel, Switzerland)

  2. Artificial intelligence is associated with accuracy in detecting vitreoretinal diseases from retinal imaging systems (PEA 95.76% (95% CI 95.0-96.47), PESen 91.94%, PESpe 96.09%).

    “yielding an overall PEA of 95.76% (95% CI: 95.0-96.47), PESen of 91.94% (95% CI: 90.72-93.08) and PESpe of 96.09% (95% CI: 95.27-96.79).”

    Reviewin detecting vitreoretinal diseases from retinal imaging systems

    Vitreoretinal disease detection using artificial intelligence: a systematic review and meta-analysis

    International ophthalmology

Atrial fibrillation

upin humans2

2 studies
  1. Artificial intelligence predicts atrial fibrillation in humans (handheld single-lead ECGs).

    “AI applied to handheld single-lead ECGs can predict incident AF with accuracy similar to established clinical risk scores”

    Reviewhandheld single-lead ECGs

    Reimagining atrial fibrillation screening beyond age-based thresholds using AI

    NPJ digital medicine

  2. Artificial intelligence is associated with atrial fibrillation in humans (subclinical or paroxysmal AF).

    “AI-enhanced electrocardiography (ECG) and wearable photoplethysmography devices allow early detection and long-term, non-invasive screening of AF”

    Reviewsubclinical or paroxysmal AF

    Artificial intelligence in atrial fibrillation - Timely diagnosis, risk assessment and personalized management

    Indian pacing and electrophysiology journal

More on Atrial fibrillation

Frailty

mixedin humans1upin reviews1

2 studies
  1. Artificial intelligence predicts frailty in scoping review of 33 publications.

    “Like the broader frailty literature, emerging AI tools lack a consistent definition of frailty, leading to design and implementation inconsistencies.”

    Reviewin scoping review of 33 publications

    Use of Conventional Artificial Intelligence Methods in the Identification of Frailty: A Scoping Review

    Journal of the American Geriatrics Society

  2. Artificial intelligence predicts frailty (moderate to high predictive performance).

    “We found that AI models achieved moderate to high predictive performance in predicting frailty.”

    Review

    Advances of artificial intelligence in predicting frailty using real-world data: A scoping review

    Ageing research reviews

Prostate cancer detection

upin humans1

1 study
  1. Artificial intelligence predicts prostate cancer detection in humans (AUC 0.93–0.97).

    “AI models achieved high diagnostic accuracy in breast (91%–98%), cervical (92%–96%), and prostate cancers (Area Under the Curve: 0.93–0.97).”

    Review

    Artificial Intelligence for Early Cancer Detection in Nigeria: A Contextual Narrative Review of Applications, Barriers, and Implementation Pathways

    Health science reports

Cervical cancer diagnostic accuracy

upin humans1

1 study
  1. Artificial intelligence predicts cervical cancer diagnostic accuracy in humans (Diagnostic accuracy 92%–96%).

    “AI models achieved high diagnostic accuracy in breast (91%–98%), cervical (92%–96%), and prostate cancers (Area Under the Curve: 0.93–0.97).”

    Review

    Artificial Intelligence for Early Cancer Detection in Nigeria: A Contextual Narrative Review of Applications, Barriers, and Implementation Pathways

    Health science reports

Breast cancer diagnostic accuracy

upin humans1

1 study
  1. Artificial intelligence predicts breast cancer diagnostic accuracy in humans (Diagnostic accuracy 91%–98%).

    “AI models achieved high diagnostic accuracy in breast (91%–98%), cervical (92%–96%), and prostate cancers (Area Under the Curve: 0.93–0.97).”

    Review

    Artificial Intelligence for Early Cancer Detection in Nigeria: A Contextual Narrative Review of Applications, Barriers, and Implementation Pathways

    Health science reports

Downstream cardiovascular prevention bottlenecks

mixedin reviews1

1 study
  1. Artificial intelligence is associated with downstream cardiovascular prevention bottlenecks.

    “this review highlights that AI mainly shifts the bottlenecks of prevention downstream, rather than removing them”

    Review

    Bottlenecks in cardiovascular prevention: Can artificial intelligence close the gap?

    Archives of cardiovascular diseases

Recurrence risk

upin humans1

1 study
  1. Artificial intelligence predicts recurrence risk in humans (treatment and prognosis).

    “pathology-based, radiomics-based, omics-based, and multimodal AI models show potential for predicting homologous recombination deficiency (HRD), platinum response, recurrence risk, and survival outcomes”

    Reviewtreatment and prognosis

    Artificial intelligence in ovarian cancer prevention and control: a brief review of detection, treatment, and equity (2021-2026)

    Frontiers in oncology

Risk prediction

upin humans1

1 study
  1. Artificial intelligence predicts risk prediction in electronic health records.

    “machine learning algorithms integrated into the electronic health records of the Unified Health System exhibit high precision in identifying patients at high risk of decompensation”

    Reviewin electronic health records

    Integration of Artificial Intelligence into Chronic Disease Screening in Family Medicine: Precision and Feasibility

    Nursing Edição Brasileira

All 37

Funding

2 grants since 2019

US Department of Veterans AffairsSwiss National Science FoundationCHF 904K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    One in silico study reports increased quality-adjusted life-years with artificial intelligence in asymptomatic females over ten years. A review reports predictive accuracy in humans and a statistically inconclusive association with breast cancer.

  2. Summary written from the findings.

Latest

Dec 2025: 3Jan 2026: 14Feb 2026: 10Mar 2026: 17Apr 2026: 8May 2026: 4Jun 2026: 8Jul 2026: 7Aug 2026: 13Sep 2026: 10Oct 2026: 7Nov 2026: 9110 papers in 12 months

See all 147 papers on artificial intelligence